Crinetics Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.

About CRNX

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.

CEO

Scott R. Struthers

CEOScott R. Struthers

Employees

290

Employees290

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2008

Founded2008

Employees

290

Employees290

CRNX Key Statistics

Market cap

4.01B

Market cap4.01B

Price-Earnings ratio

-12.88

Price-Earnings ratio-12.88

Dividend yield

—

Dividend yield—

Average volume

651.81K

Average volume651.81K

High today

$51.29

High today$51.29

Low today

$48.47

Low today$48.47

Open price

$50.06

Open price$50.06

Volume

1.93M

Volume1.93M

52 Week high

$51.29

52 Week high$51.29

52 Week low

$15.76

52 Week low$15.76

CRNX News

TipRanks 3h

Crinetics Pharmaceuticals Showcases Research at ENDO 2024 - TipRanks.com - TipRanks

Crinetics Pharmaceuticals (CRNX) has shared an update. Crinetics Pharmaceuticals, Inc. is set to present five abstracts from its clinical development program a...

Analyst ratings

93%

of 14 ratings

Buy

92.9%

Hold

7.1%

Sell